Cargando…

Diagnostic Accuracy of PET/CT or PET/MRI Using PSMA-Targeting Radiopharmaceuticals in High-Grade Gliomas: A Systematic Review and a Bivariate Meta-Analysis

Background: Several studies proposed the use of positron emission tomography (PET) with Prostate Specific Membrane Antigen (PSMA)-targeting radiopharmaceuticals in brain tumors. Our aim is to calculate the diagnostic accuracy of these methods in high-grade gliomas (HGG) with a bivariate meta-analysi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muoio, Barbara, Albano, Domenico, Dondi, Francesco, Bertagna, Francesco, Garibotto, Valentina, Kunikowska, Jolanta, Piccardo, Arnoldo, Annunziata, Salvatore, Espeli, Vittoria, Migliorini, Denis, Treglia, Giorgio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323081/ https://www.ncbi.nlm.nih.gov/pubmed/35885569 http://dx.doi.org/10.3390/diagnostics12071665

Ejemplares similares

The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review
por: Rizzo, Alessio, et al.
Publicado: (2023)

Paget Disease as Common Pitfall on PET with Different Radiopharmaceuticals in Oncology: Not All That Glitters Is Gold!
por: Dondi, Francesco, et al.
Publicado: (2022)

Bone Scintigraphy versus PSMA-Targeted PET/CT or PET/MRI in Prostate Cancer: Lessons Learned from Recent Systematic Reviews and Meta-Analyses
por: Dondi, Francesco, et al.
Publicado: (2022)

Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas
por: Bertagna, Francesco, et al.
Publicado: (2020)

Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Hepatocellular Carcinoma Using Positron Emission Tomography? An Updated Systematic Review and Meta-Analysis
por: Rizzo, Alessio, et al.
Publicado: (2022)

Diagnostic Performance of (18)F-FDG PET or PET/CT for Detection of Post-Transplant Lymphoproliferative Disorder: A Systematic Review and a Bivariate Meta-Analysis
por: Ballova, Veronika, et al.
Publicado: (2020)

Potential Role of PSMA-Targeted PET in Thyroid Malignant Disease: A Systematic Review
por: Rizzo, Alessio, et al.
Publicado: (2023)

The Role of [(68)Ga]Ga-Pentixafor PET/CT or PET/MRI in Lymphoma: A Systematic Review
por: Albano, Domenico, et al.
Publicado: (2022)

Could [(18)F]FDG PET/CT or PET/MRI Be Useful in Patients with Skull Base Osteomyelitis?
por: Dondi, Francesco, et al.
Publicado: (2022)

Emerging Role of FAPI PET Imaging for the Assessment of Benign Bone and Joint Diseases
por: Dondi, Francesco, et al.
Publicado: (2022)

PET with Different Radiopharmaceuticals in Neuroendocrine Neoplasms: An Umbrella Review of Published Meta-Analyses
por: Treglia, Giorgio, et al.
Publicado: (2021)

Prevalence of Brain Incidental Lesions Detected by (68)Ga-DOTA Peptides PET/CT
por: Albano, Domenico, et al.
Publicado: (2022)

Role of 2-[(18)F]FDG as a Radiopharmaceutical for PET/CT in Patients with COVID-19: A Systematic Review
por: Annunziata, Salvatore, et al.
Publicado: (2020)

Diagnostic Performance and Prognostic Value of PET/CT with Different Tracers for Brain Tumors: A Systematic Review of Published Meta-Analyses
por: Treglia, Giorgio, et al.
Publicado: (2019)

The “Undetermined Significance” of (18)F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
por: Treglia, Giorgio, et al.
Publicado: (2021)

Role of Radiomics Features and Machine Learning for the Histological Classification of Stage I and Stage II NSCLC at [(18)F]FDG PET/CT: A Comparison between Two PET/CT Scanners
por: Dondi, Francesco, et al.
Publicado: (2022)

(18)F-FDG PET and PET/CT for the evaluation of gastric signet ring cell carcinoma: a systematic review
por: Dondi, Francesco, et al.
Publicado: (2021)

(18)F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor?
por: Albano, Domenico, et al.
Publicado: (2023)

Relationship between Baseline [(18)F]FDG PET/CT Semiquantitative Parameters and BRCA Mutational Status and Their Prognostic Role in Patients with Invasive Ductal Breast Carcinoma
por: Dondi, Francesco, et al.
Publicado: (2022)

Diagnostic Role of (18)F-PSMA-1007 PET/CT in Prostate Cancer Staging: A Systematic Review
por: Awenat, Salam, et al.
Publicado: (2021)

Longitudinal Body Composition Changes Detected by [(18)F]FDG PET/CT during and after Chemotherapy and Their Prognostic Role in Elderly Hodgkin Lymphoma
por: Albano, Domenico, et al.
Publicado: (2022)

PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review
por: Dondi, Francesco, et al.
Publicado: (2023)

Head-to-Head Comparison between (18)F-FES PET/CT and (18)F-FDG PET/CT in Oestrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-Analysis
por: Piccardo, Arnoldo, et al.
Publicado: (2022)

Incidental Unilateral Tuberculous Sacroiliitis Detected by (18)F-FDG PET/CT in a Patient with Abdominal Tuberculosis
por: Albano, Domenico, et al.
Publicado: (2017)

Diagnostic Performance of PET Imaging Using Different Radiopharmaceuticals in Prostate Cancer According to Published Meta-Analyses
por: Annunziata, Salvatore, et al.
Publicado: (2020)

Diagnostic and Prognostic Role of (18)F-Fluoroestradiol PET in Metastatic Breast Cancer: The Second Youth of an Older Theranostic Concept
por: Fiz, Francesco, et al.
Publicado: (2022)

PET Radiopharmaceuticals
por: Shahhosseini, Soraya
Publicado: (2011)

Prognostic Impact of Pretreatment 2-[(18)F]-FDG PET/CT Parameters in Primary Gastric DLBCL
por: Albano, Domenico, et al.
Publicado: (2021)

Prognostic Role of 2-[(18)F]FDG PET/CT Metabolic Volume Parameters in Patients Affected by Differentiated Thyroid Carcinoma with High Thyroglobulin Level, Negative (131)I WBS and Positive 2-[(18)F]-FDG PET/CT
por: Albano, Domenico, et al.
Publicado: (2021)

Role of (18)F-FDG PET/CT Radiomics Features in the Differential Diagnosis of Solitary Pulmonary Nodules: Diagnostic Accuracy and Comparison between Two Different PET/CT Scanners
por: Albano, Domenico, et al.
Publicado: (2021)

Neuro-Oncology and Positron Emission Tomography: “Just Can’t Get Enough”
por: Muoio, Barbara, et al.
Publicado: (2023)

Diagnostic Performance of PET or PET/CT Using (18)F-FDG Labeled White Blood Cells in Infectious Diseases: A Systematic Review and a Bivariate Meta-Analysis
por: Meyer, Marie, et al.
Publicado: (2019)

Prognostic Role of Pre-Treatment Metabolic Parameters and Sarcopenia Derived by 2-[(18)F]-FDG PET/CT in Elderly Mantle Cell Lymphoma
por: Albano, Domenico, et al.
Publicado: (2022)

Comparison between Two Different Scanners for the Evaluation of the Role of (18)F-FDG PET/CT Semiquantitative Parameters and Radiomics Features in the Prediction of Final Diagnosis of Thyroid Incidentalomas
por: Dondi, Francesco, et al.
Publicado: (2022)

The role of Tg kinetics in predicting 2-[(18)F]-FDG PET/CT results and overall survival in patients affected by differentiated thyroid carcinoma with detectable Tg and negative 131I-scan
por: Albano, Domenico, et al.
Publicado: (2021)

(18)F-FDG PET/CT in Pleural Epithelioid Hemangioendothelioma
por: Albano, Domenico, et al.
Publicado: (2017)

Performance of (18)F-FDG PET/CT in Selecting Thyroid Nodules with Indeterminate Fine-Needle Aspiration Cytology for Surgery. A Systematic Review and a Meta-Analysis
por: Castellana, Marco, et al.
Publicado: (2019)

Thyroid metastasis from lung carcinoid detected by (68)Ga-DOTATOC PET/CT
por: Albano, Domenico, et al.
Publicado: (2021)

Towards an Automated Approach to the Semi-Quantification of [(18)F]F-DOPA PET in Pediatric-Type Diffuse Gliomas
por: Peira, Enrico, et al.
Publicado: (2023)

The dilemma of (18)F-FDG PET/CT thyroid incidentaloma: what we should expect from FNA. A systematic review and meta-analysis
por: Scappaticcio, Lorenzo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rdiogamrng57pjcuh8s1641557